Finally! Will this be the much needed push for Indian Pharma Industry??
The
Cabinet Committee on Economic Affairs (CCEA), chaired by Prime Minister
Narendra Modi, on last Wednesday approved Rs 1,750 crore for strengthening drug
regulatory systems at both central and state levels. Of the amount, an amount
of Rs.900 crore will be spent on strengthening central structures and Rs.850
crore will be made available to the state governments, said a cabinet
communique.
The
regulatory upgradation will give additional equipment and manpower to the
existing drug testing laboratories, establish new labs for testing drugs,
medical devices and cosmetics and introduce mobile drug testing laboratories. The
upgradation also includes the creation of additional manpower for regulatory
structures in the emerging areas of stem cell, regenerative medicine,
biologicals and medical devices.
Other
measures include introduction of organization wide e-governance and IT
enabled/online services, setting up of a training academy for regulatory and
drug testing officials for both central and state governments.
The
strengthening measures are also aimed at mitigating the disease burden of India
and to propel the export of pharmaceutical products. India is one of the
largest manufacturers of medicines and exports to as many as 200 countries. The
drug regulatory system strengthening and upgradation exercise will be executed
during a time period of three years.
Your
comments are welcome.
Comments
Post a Comment